Charles River Laboratories CRL Payment for (Proceeds from) Other Investing Activity
Payment for (Proceeds from) Other Investing Activity at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's payment for (proceeds from) other investing activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's payment for (proceeds from) other investing activity?
- Charles River Laboratories (CRL) reported payment for (proceeds from) other investing activity of $1.46M in Q1 2026.
- How has Charles River Laboratories's payment for (proceeds from) other investing activity changed year-over-year?
- Charles River Laboratories's payment for (proceeds from) other investing activity increased by 1501.0% year-over-year, from -$104K to $1.46M.
- What is the long-term trend for Charles River Laboratories's payment for (proceeds from) other investing activity?
- Over 3 years (2022 to 2025), Charles River Laboratories's payment for (proceeds from) other investing activity has grown at a -28.9% compound annual growth rate (CAGR), from $9.35M to -$3.36M.
- What does payment for (proceeds from) other investing activity mean?
- Miscellaneous cash inflows or outflows related to investing activities.
- How do you interpret payment for (proceeds from) other investing activity?
- Large fluctuations may indicate non-recurring events or specific accounting adjustments that require further investigation in the financial notes.
- How does payment for (proceeds from) other investing activity compare across companies?
- Often found as a 'catch-all' line item in the investing section of the cash flow statement.